3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis

BACKGROUND: Concurrent chemoradiotherapy with cisplatin is standard for patients (pts) with loco-regionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) and for patients with resected SCCHN with high-risk features. The standard regimen includes 3-weekly cisplatin, but weekly regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Helfenstein, Seth, Riesterer, Oliver, Meier, Urs R., Papachristofilou, Alexandros, Kasenda, Benjamin, Pless, Miklos, Rothschild, Sacha I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371614/
https://www.ncbi.nlm.nih.gov/pubmed/30744643
http://dx.doi.org/10.1186/s13014-019-1235-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371614/
https://www.ncbi.nlm.nih.gov/pubmed/30744643
http://dx.doi.org/10.1186/s13014-019-1235-y

Ejemplares similares